Efficacy and Safety of liraglutide in combination with metformin versus metformin monotherapy on glycaemic control in children and adolescents with type 2 diabetes

Grants and Contracts Details

StatusFinished
Effective start/end date7/14/167/13/18

Funding

  • Novo Nordisk Pharmaceuticals Inc: $10,502.00